Cover Image

Mapping the Causal Landscape of Psoriasis: A Systematic Mendelian Randomization Evidence Synthesis and Development of the MR ‐ PsO Atlas Platform

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Jin‐Yu Lu, Wenling Zeng, Kexin Wang, Junlin Zhou, Wenhao Pan, Qiaoming Fan, Qingyi Yang, Manting Liu, Kai‐Fang Ren
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	Experimental Dermatology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Association of Cardiometabolic Index in Psoriasis: Evidence From the National Health and Nutrition Examination Survey
by: Hao Ren, et al.
Published: (2026)

Potential Causal Relationship Between Extensive Lipid Profiles and Various Hair Loss Diseases: Evidence From Univariable and Multivariable Mendelian Randomization Analyses
by: Yuhan Xie, et al.
Published: (2025)

Use of Oral JAK Inhibitors and a TYK2 Inhibitor in the Treatment of Psoriasis–Eczema Overlap ( PsEma ): A Retrospective Study
by: Marley Cutrona, et al.
Published: (2026)

The Causal Relationship Between Acne Vulgaris and BMI: A Mendelian Randomization Study
by: Zhifeng Li, et al.
Published: (2025)

More Active Hair Growth in Human Scalp Psoriasis and Mouse Psoriasis: Evidence for the Same “Switch‐On” of Psoriasis and Hair Growth
by: Chenxingyue Zhang, et al.
Published: (2025)

Experience of living with psoriasis in Brazil: a Global Psoriasis Atlas online survey
by: Jaquelini Barboza da Silva, et al.
Published: (2024)

Applications of Traditional Herbal Ingredients in Skincare: Mapping the Research Landscape and Innovation Trajectories Over Four Decades
by: Kexin Deng, et al.
Published: (2025)

Unraveling the Causal Relationship Between Blood Metabolites and Acne: A Metabolomic Mendelian Randomization Study
by: Min Li, et al.
Published: (2024)

Causal effects of lipid‐lowering drugs on inflammatory skin diseases: Evidence from drug target Mendelian randomisation
by: Chenyang Zang, et al.
Published: (2024)

Deucravacitinib in Psoriasis: Evidence, Gaps, and Place in Therapy
by: Ece Gokyayla, et al.
Published: (2025)

Causal Association Between Inflammatory Factors and Hypertrophic Scar: A Two‐Sample Mendelian Randomization Study
by: Yanqi Li, et al.
Published: (2025)

Association of Dietary Intake With the Risk of Atopic Diseases: A Mendelian Randomization Study
by: Xixia Dai, et al.
Published: (2025)

Psoriasis in People With Skin of Color: An Evidence‐Based Update
by: Maria‐Angeliki Gkini, et al.
Published: (2025)

What is Psoriasis?
Published: (2025)

Effectiveness of Biologics on Preventing the Development of Psoriatic Arthritis in Psoriasis Patients: A Systematic Review
by: Kathleen L. Miao, et al.
Published: (2026)

Beverage Consumption and Facial Skin Aging: Evidence From Mendelian Randomization Analysis: Comment From Liu et al
by: Hainan Li, et al.
Published: (2024)

Comment on “Psoriasis may increase the risk of lung cancer: A two‐sample Mendelian randomization study”
by: Lingli Huang, et al.
Published: (2024)

Study on the Potential Molecular Mechanism of Keloid Disease Associated With Single Cell Combined Mendelian Randomization
by: Hui‐Hui Wu, et al.
Published: (2026)

Correction to “Safety and Effectiveness of Ixekizumab in Japanese Patients with Psoriasis Vulgaris, Psoriatic Arthritis, Generalized Pustular Psoriasis, and Erythrodermic Psoriasis: Post‐marketing Surveillance”
Published: (2025)

The Impacts of Seasonal Factors on Psoriasis
by: Jundan Yang, et al.
Published: (2025)

Circulating Cytokine Levels and the Risk of Hypertrophic Scar: A Two‐Sample Mendelian Randomization Study
by: Xi Xu, et al.
Published: (2025)

A Systematic Review of Mendelian Pyoderma Gangrenosum: Clinical and Genetic Characteristics in 120 Published Patients
by: Leyla Norouzi‐Barough, et al.
Published: (2025)

Real‐World Guselkumab Response and Drug Survival in Australian Patients With Psoriasis: Results From the Australasian Psoriasis Registry
by: Nicholas Manuelpillai, et al.
Published: (2024)

Evaluating Psoriasis Severity Using the Neutrophil‐to‐Lymphocyte Ratio and Platelet‐to‐Lymphocyte Ratio: A Systematic Review and Meta‐Analysis
by: Yi‐Hsuan Shen, et al.
Published: (2026)

Causal relationship between metabolic syndrome and hidradenitis suppurativa: A two‐sample bidirectional Mendelian randomization study
by: Xinxin Luo, et al.
Published: (2024)

‘Psoriasis Punctata’: An Under‐Recognised Clinical Phenotype of TNF‐Alpha Inhibitor‐Induced Psoriasis
by: Grace Im, et al.
Published: (2025)

Beverage consumption and facial skin aging: Evidence from Mendelian randomization analysis
by: Xuanchen Liu, et al.
Published: (2024)

Improving Cardiovascular Outcomes in the Psoriasis Cohort. Psoriasis and Cardiovascular Disease–Patient Knowledge, Perspectives and Practice
by: Annika Smith, et al.
Published: (2025)

Improving Cardiovascular Outcomes in the Psoriasis Cohort. Psoriasis and Cardiovascular Disease—Clinician Knowledge, Practice and Perceptions
by: Annika Smith, et al.
Published: (2025)

The relationship between smoking and rosacea: A Mendelian randomization study
by: YuJia Cai, et al.
Published: (2024)

Skin Microbiota and Pathological Scars: A Bidirectional Two‐Sample Mendelian Randomization Study
by: Ying Huang, et al.
Published: (2024)

Psoriasis management tree based on comorbidity
by: Shivkar Amara, et al.
Published: (2024)

Clinical Characteristics and Treatment Patterns of Psoriasis in Asia and Switzerland: Results of the Multicentre Global Healthcare Study on Psoriasis (GHSP)
by: Eyan Goh, et al.
Published: (2025)

Efficacy of Biologics for the Treatment of Moderate‐To‐Severe Plaque Psoriasis in the Asian Population: A Systematic Review and Network Meta‐Analysis
by: Akihiko Asahina, et al.
Published: (2025)

A Case of Palmoplantar Psoriasis Successfully Treated With Tapinarof Cream
by: Ayako Hiraishi, et al.
Published: (2025)

Spesolimab for Generalized Pustular Psoriasis in the Late Second Trimester of Pregnancy
by: Miyuki Kato, et al.
Published: (2026)

Genital Psoriasis in Asians: Impact on Quality of Life and Sexual Health
by: Kim Yao Ong, et al.
Published: (2025)

Clinical Experience of Risankizumab in Patients With a History of Erythrodermic Psoriasis
by: Che‐Chia Hsu, et al.
Published: (2025)

The Sustainability of Week 16 Responses to Deucravacitinib Treatment for Patients With Psoriasis
by: Mizuki Shiba, et al.
Published: (2025)

The Role of the Major Histocompatibility Complex Region on Chromosome 6 in Skin Atrophy: A Mendelian Randomization Study
by: Chenyu Zhao, et al.
Published: (2025)